Comparing with normal tissues, higher expression of SRGN was found in brain and CNS (central nervous system) cancer, esophageal cancer, head and neck cancer, kidney cancer, liver cancer, lymphoma, and melanoma while lower expression was found in bladder cancer, breast cancer, colorectal cancer, and lung cancer (Fig. 1a). This evidence concerns the gene SRGN and lung cancer.